IT8367372A0 - Procedimento per stabilizzare un fattore avente effetto necrotizzante sui tumori e soluzione acquosa stabile o polvere che lo contiene - Google Patents

Procedimento per stabilizzare un fattore avente effetto necrotizzante sui tumori e soluzione acquosa stabile o polvere che lo contiene

Info

Publication number
IT8367372A0
IT8367372A0 IT8367372A IT6737283A IT8367372A0 IT 8367372 A0 IT8367372 A0 IT 8367372A0 IT 8367372 A IT8367372 A IT 8367372A IT 6737283 A IT6737283 A IT 6737283A IT 8367372 A0 IT8367372 A0 IT 8367372A0
Authority
IT
Italy
Prior art keywords
tumors
stabilize
factor
powder
procedure
Prior art date
Application number
IT8367372A
Other languages
English (en)
Other versions
IT8367372A1 (it
IT1162845B (it
Inventor
Hajimu Sakamoto Takao Kiyota
Hiroshi Hayashi
Original Assignee
Asahi Chemical Ind
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26397663&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT8367372(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP57056690A external-priority patent/JPS58174330A/ja
Priority claimed from JP57129560A external-priority patent/JPS5920225A/ja
Application filed by Asahi Chemical Ind, Dainippon Pharmaceutical Co filed Critical Asahi Chemical Ind
Publication of IT8367372A0 publication Critical patent/IT8367372A0/it
Publication of IT8367372A1 publication Critical patent/IT8367372A1/it
Application granted granted Critical
Publication of IT1162845B publication Critical patent/IT1162845B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT67372/83A 1982-04-07 1983-04-05 Procedimento per stabilizzare un fattore avente effetto necrotizzante sui tumori e soluzione acquosa stabile o polvere che lo contiene IT1162845B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57056690A JPS58174330A (ja) 1982-04-07 1982-04-07 ガン壊死因子の安定化法
JP57129560A JPS5920225A (ja) 1982-07-27 1982-07-27 ガン壊死因子の安定化方法

Publications (3)

Publication Number Publication Date
IT8367372A0 true IT8367372A0 (it) 1983-04-05
IT8367372A1 IT8367372A1 (it) 1984-10-05
IT1162845B IT1162845B (it) 1987-04-01

Family

ID=26397663

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67372/83A IT1162845B (it) 1982-04-07 1983-04-05 Procedimento per stabilizzare un fattore avente effetto necrotizzante sui tumori e soluzione acquosa stabile o polvere che lo contiene

Country Status (10)

Country Link
US (1) US4447355A (it)
EP (1) EP0091258B2 (it)
KR (1) KR860000842B1 (it)
CA (1) CA1187412A (it)
CH (1) CH656534A5 (it)
DE (1) DE3373628D1 (it)
ES (1) ES521266A0 (it)
FR (1) FR2530472B1 (it)
HU (1) HU189251B (it)
IT (1) IT1162845B (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019719A (ja) * 1983-07-15 1985-01-31 Asahi Chem Ind Co Ltd 抗腫瘍活性を有する蛋白質
US4524026A (en) * 1983-08-29 1985-06-18 Yoshio Sakagami Novel proteinous cancer-cell proliferation inhibitory factors
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
JPS60260522A (ja) 1984-06-07 1985-12-23 Asahi Chem Ind Co Ltd 遺伝子組換体が生産する生理活性物質の安定化法
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US5840522A (en) * 1984-09-20 1998-11-24 Chiron Corporation Recombinant lectins
US4677063A (en) * 1985-05-02 1987-06-30 Cetus Corporation Human tumor necrosis factor
US4677064A (en) * 1984-11-09 1987-06-30 Cetus Corporation Human tumor necrosis factor
WO1986005204A1 (fr) * 1985-03-04 1986-09-12 Sawai Pharmaceutical Co., Ltd. Nouvelle substance induisant le facteur necrosique tumoral et provenant de bacteries resistantes aux acides
US6084073A (en) * 1985-03-25 2000-07-04 Chiron Corporation Recombinant ricin toxin
US4870163A (en) * 1985-08-29 1989-09-26 New York Blood Center, Inc. Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor
US4770995A (en) * 1985-08-29 1988-09-13 New York Blood Center, Inc Detection of the sensitivity of cells to the effects of tumor necrosis factor and lymphotoxin
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3631413A1 (de) * 1986-09-16 1988-03-24 Knoll Ag Therapeutisches system zur lokalen applikation von pharmawirkstoffen
US5215743A (en) * 1988-04-13 1993-06-01 Maninder Singh Tumor necrosis factor formulations
DE3839639A1 (de) * 1988-11-24 1990-05-31 Basf Ag Verwendung von tnf bei der behandlung von hautkrankheiten
US5223395A (en) * 1988-12-01 1993-06-29 Centocor, Inc. Immunometric assays for tumor necrosis factor-alpha and methods for preventing the loss of biological activity of tumor necrosis factor-alpha in biological samples
US5653974A (en) * 1990-10-18 1997-08-05 Board Of Regents,The University Of Texas System Preparation and characterization of liposomal formulations of tumor necrosis factor
ATE147976T1 (de) * 1991-01-15 1997-02-15 Hemosphere Inc Protein nanomatrizen und verfahren zur herstellung
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
US5556771A (en) * 1995-02-10 1996-09-17 Gen-Probe Incorporated Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
ES2180416B1 (es) 2001-03-12 2004-06-01 BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. Procedimiento para la preparacion de mezclas de reaccion estabilizadas, total o parcialmente desecadas, que comprenden, al menos, una enzima, mezclas de reaccion y kits que las contienen.
US7285269B2 (en) * 2002-12-02 2007-10-23 Amgen Fremont, Inc. Antibodies directed to tumor necrosis factor
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637640A (en) * 1970-05-04 1972-01-25 Diagnostic Data Inc Orgotein stabilized with saccharide process and products
JPS5668607A (en) * 1979-11-07 1981-06-09 Teikoku Hormone Mfg Co Ltd Medical preparation with storage stability

Also Published As

Publication number Publication date
ES8505546A1 (es) 1985-06-01
CA1187412A (en) 1985-05-21
CH656534A5 (fr) 1986-07-15
IT8367372A1 (it) 1984-10-05
FR2530472A1 (fr) 1984-01-27
DE3373628D1 (en) 1987-10-22
KR840004365A (ko) 1984-10-15
US4447355A (en) 1984-05-08
FR2530472B1 (fr) 1986-04-25
ES521266A0 (es) 1985-06-01
EP0091258B2 (en) 1992-12-16
IT1162845B (it) 1987-04-01
HU189251B (en) 1986-06-30
EP0091258A2 (en) 1983-10-12
EP0091258B1 (en) 1987-09-16
KR860000842B1 (ko) 1986-07-09
EP0091258A3 (en) 1984-09-19

Similar Documents

Publication Publication Date Title
IT8367886A0 (it) Procedimento per stabilizzare un fattore avente effetto necrotizzante sui tumori e soluzione acquosa stabile o polvere che lo contiene
IT8367372A0 (it) Procedimento per stabilizzare un fattore avente effetto necrotizzante sui tumori e soluzione acquosa stabile o polvere che lo contiene
DK80884A (da) Inhalationsapparat
FI812405L (fi) Inhalator
ATA265282A (de) Inhalator
IT1171646B (it) Composti benzoeterociclici e procedimento per prepararli
IT8049783A0 (it) Pentaidrato di cefalosporina composizioni che lo contengono e relativo procedimento di preparazione ed applicazione
FR2545722B1 (fr) Inhalateur
ES526480A0 (es) Procedimiento para la preparacion de polifosfato amonico activado
DE3373810D1 (de) Fungicidal anilides
DK274285D0 (da) Inhalationsapparat
IT1175691B (it) Vaporizzatore di anestetico
DK209983D0 (da) Knoglesoem
IT1143160B (it) Collante termcindurente
FR2528507B1 (fr) Mousqueton
IT1173654B (it) Impiego di colecalciferol-derivati
FI831788A0 (fi) Spaenningsstyrd oscillator
DD262551A3 (de) Verdampfer
FR2520140B1 (fr) Indicateur electromagnetique
IT1172258B (it) Composti erbicidi e procedimento di preparazione
DK118583A (da) Applikator
DK38183A (da) Nasalpraeparat
SE411124B (sv) Ben- eller hudlim innehallande en kvarter ammoniumforening
FR2554581B1 (fr) Detecteur angulaire electromagnetique
BR6201097U (pt) Conjunto para aplicacao de inalacoes

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970429